These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 184945)

  • 1. Protein phosphotransferase activities and cyclic nucleotide action in proliferating lymphocytes.
    Masaracchia RA; Walsh DA
    Cancer Res; 1976 Sep; 36(9 pt.1):3227-37. PubMed ID: 184945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of adenosine 3':5'-monophosphate-dependent protein kinase activation and inhibition of thymidine incorporation into DNA in P1798 lymphosarcoma cells.
    Michnoff CA; de la Houssaye BA; Masaracchia RA
    Cancer Res; 1983 Aug; 43(8):3514-20. PubMed ID: 6305487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation of regulatory subunit of type I cyclic AMP-dependent protein kinase: biphasic effects of cyclic AMP in intact S49 mouse lymphoma cells.
    Russell JL; Steinberg RA
    J Cell Physiol; 1987 Feb; 130(2):207-13. PubMed ID: 3029147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandin-E2-induced activation of adenosine 3'-5' cyclic monophosphate-dependent protein kinases of a murine macrophage-like cell line (P388D1).
    Yamamoto H; Suzuki T
    J Immunol; 1987 Nov; 139(10):3416-21. PubMed ID: 2824605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormonal regulation of adenosine 3',5'-monophosphate-dependent protein kinase.
    Corbin JD; Keely SL; Soderling TR; Park CR
    Adv Cyclic Nucleotide Res; 1975; 5():265-79. PubMed ID: 165670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of the regulatory subunit of type I adenosine cyclic 3':5'-monophosphate-dependent protein kinase in differentiated N-18 mouse neuroblastoma cells.
    Liu AY; Chan T; Chen KY
    Cancer Res; 1981 Nov; 41(11 Pt 1):4579-87. PubMed ID: 6272981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of soluble cyclic adenosine monophosphate-dependent protein kinase isozymes in murine embryonic palatal tissue.
    Greene RM; Linask KK; Pisano MM; Lloyd MR
    J Craniofac Genet Dev Biol; 1989; 9(2):207-22. PubMed ID: 2794008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional changes in the regulatory subunit of the type II cyclic adenosine 3':5'-monophosphate-dependent protein kinase isozyme during normal and neoplastic lung development.
    Butley MS; Beer DG; Malkinson AM
    Cancer Res; 1984 Jun; 44(6):2689-97. PubMed ID: 6327022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of cyclic nucleotide binding to adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate-dependent protein kinases.
    Buss JE; McCune RW; Gill GN
    J Cyclic Nucleotide Res; 1979; 5(3):225-37. PubMed ID: 225357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic activation of insect cAMP-dependent protein kinase A (type II) by cyclicAMP and cyclicGMP.
    Leboulle G; Müller U
    FEBS Lett; 2004 Oct; 576(1-2):216-20. PubMed ID: 15474040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A hypothesis concerning the structure of cAMP-and cGMP-dependent protein kinases.
    Gill GN
    J Cyclic Nucleotide Res; 1977 Jun; 3(3):153-62. PubMed ID: 198441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in cyclic adenosine 3':5'-monophosphate-dependent protein kinases during the progression of urethan-induced mouse lung tumors.
    Butley MS; Stoner GD; Beer DG; Beer DS; Mason RJ; Malkinson AM
    Cancer Res; 1985 Aug; 45(8):3677-85. PubMed ID: 2990675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclic AMP-dependent protein kinases from Balb 3T3 cells and other 3T3 derived lines.
    Wehner JM; Malkinson AM; Wiser MF; Sheppard JR
    J Cell Physiol; 1981 Aug; 108(2):175-84. PubMed ID: 6267082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
    Marcoz P; Prigent AF; Lagarde M; Nemoz G
    Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in protein kinase C and cAMP-dependent kinase in lymphocytes after treatment with 12-O-tetradecanoylphorbol-13-acetate or concanavalin A: quantitation of activities with an in situ gel assay.
    Grove DS; Mastro AM
    J Cell Physiol; 1987 Sep; 132(3):415-27. PubMed ID: 2821014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of the activity of protein kinases by endogenous heat stable protein inhibitors.
    Szmigielski A
    Pol J Pharmacol Pharm; 1985; 37(3):273-83. PubMed ID: 2999738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution and properties of type I and type II binding proteins in the cyclic adenosine 3':5'-monophosphate-dependent protein kinase system in Wilms' tumor.
    Nakajima F; Imashuku S; Wilimas J; Champion JE; Green AA
    Cancer Res; 1984 Nov; 44(11):5182-7. PubMed ID: 6091871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the dominance of mutations in cAMP-binding sites of murine type I cAMP-dependent protein kinase in activation of kinase from heterozygous mutant lymphoma cells.
    Shuntoh H; Steinberg RA
    J Cell Physiol; 1991 Jan; 146(1):86-93. PubMed ID: 1846638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of contractile activity in vascular smooth muscle by protein kinases.
    Silver PJ
    Rev Clin Basic Pharm; 1985; 5(3-4):341-95. PubMed ID: 3029813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the cyclic adenosine 3':5'-monophosphate effector system in hormone-dependent and hormone-independent rat mammary carcinomas.
    Ogreid D; Cho-Chung YS; Ekanger R; Vintermyr O; Haavik J; Døskeland SO
    Cancer Res; 1987 May; 47(10):2576-82. PubMed ID: 3032409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.